Human immunodeficiency virus type 1 (HIV-1)-infected cells respond to the infection with different outcomes depending on their cell type. The interplay of cellular and viral proteins is a key player of differences in virus replication and disease progression. Myeloid cells, including monocytes, macrophages, and myeloid dendritic cells (mDCs) play a crucial role in the transmission and pathogenesis of HIV. The viral protein Tat, which is the viral transcriptional activator, modulates the expression of both HIV and cellular genes in these myeloid cells. This review will focus on recent advances on the interplay between HIV and myeloid cells and will discuss how this interaction may contribute to HIV pathogenesis. A better understanding of the pathogenesis of HIV disease will provide us with the scientific rationale for novel approaches to prevention.
Introduction

Human immunodeficiency virus (HIV) infects
However, myeloid cells also stimulate the adaptive immune responses via antigen presentation and the recruitment and activation of lymphocytes, and they are also involved in numerous aspects of tissue function and homeostasis.
Monocytes are precursors of macrophages and mDCs that originate in the bone marrow and circulate in the peripheral blood before homing into tissues. While in the blood, monocytes contribute to innate immune defenses via the ability to detect numerous pathogen-associated molecular patterns (PAMPs), to phagocytose, and to produce reactive oxygen and nitrogen species (Fig. 1) (6) . Once present in tissues, monocytes differentiate into macrophages or mDCs depending on signals they receive from the local microenvironment (7). Tissue-based macrophages are critical cells involved in immune surveillances and anti-microbial defenses. Their goal is typically to maintain tissue homeostasis through the ingestion and ultimately the removal of apoptotic and necrotic cells. Macrophages and mDCs express a battery of pattern recognition receptors (PRRs) and when faced with foreign antigens they are able to rapidly phagocytose and kill microbes, and/or to generate numerous cytokines and chemokines to recruit and activate additional immune cells. Moreover, while these cells contribute to inflammation and immune activation, they also likely resolve these responses by producing anti-inflammatory cytokines and suppressing the activity of other immune cells (6) . . Chemokine receptors such as CCR2 and CX3CR1 direct the migration of blood monocytes to sites of inflammation (②), where they contribute to the pro-inflammatory cytokine milieu through the production of TNF-α, IL-6, IL-8, and IL-1β (③). Once present in tissues, monocytes are influenced by local signals to differentiate into either macrophages or mDCs. In vitro, M-CSF directs monocyte differentiation into macrophages while GM-CSF + IL-4 results in differentiation into mDCs (④). Tissue resident macrophages are also capable of producing pro-inflammatory cytokines as well as ample amounts of IL-10, an anti-inflammatory cytokine important for resolving local inflammation (③). Both monocytes and macrophages are capable of phagocytosis and intracellular killing of microbes through the production of reactive oxygen species (ROS) and reactive nitrogen species (⑤). Activated macrophages and mDCs secrete IL-12, a cytokine involved in the activation and differentiation of T cells (⑥). Activated mDCs also stimulate NK cell activation via the production of IL-15 and IL-18 (⑦). Adapted from "The myeloid cytokine network in AIDS pathogenesis", by Mir et al., 2012 , Cytokine Growth Factor Rev, 23, 224 as a reference 6 in the text. (Fig. 4) (53) . A species-specific increase of This dual arrangement may be important to favor both the persistence and high level replication of this pathogen in its infected host.
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